Review analyzes biomarkers p16INK4a and SA-β-gal in cellular senescence detection, suggesting multi-omics improves accuracy.
Cellular senescence is a fundamental mechanism underlying organismal aging and the development of numerous age-related diseases. Accurate detection of senescent cells is key for understanding and intervening in the aging process. Molecules such as p16INK4a, p21, and SA-β-gal have been widely used in senescence detection. Traditional SA-β-gal staining is popular for its simplicity, but emerging high-throughput spatial omics techniques, such as seqFISH, now enable high-resolution and dynamic multi-marker tracking of senescent cells. Using multi-omics and spatial approaches, researchers are elucidating the distribution and molecular heterogeneity of senescent cells in tissues. However, existing detection methods still lack in specificity, throughput, and clinical utility, and a universal, standardized high-precision detection system remains elusive. This review systematically analyzes the molecular mechanisms and detection methods for p16INK4a, p21, and SA-β-gal, evaluates technological developments from classical biochemical methods to innovative spatial transcriptomics (ST), discusses the potential of single-cell multi-omics and novel biomarkers for improving detection accuracy and understanding senescence heterogeneity, and summarizes limitations and challenges faced by each approach. The results suggest that integrating multi-marker and spatial omics technology can significantly enhance the accuracy and resolution of senescent cell detection, providing a technical basis for developing innovative anti-aging drugs and disease interventions. This study provides reference for optimizing senescent cell detection and biomarker screening, emphasizing the importance of a standardized multi-omics system. Future directions should focus on improving clinical translatability, exploring molecular regulation and cellular heterogeneity within the senescent microenvironment, and advancing disease diagnosis and healthy aging.
No takes yet. Share an insight, caveat, or question.
Mengyang Li (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: